operates the world's largest validated brain-behavioral dataset. The platform's proprietary signal moat -- built on an exclusive license to clinical-grade EEG technology developed at UPenn Medicine -- cannot be replicated by AI or modeled proxies. GlassView also holds an equity stake in Cogwear, the neuroscience company behind its hardware, whose clinical-grade EEG sensor technology powers NIH-funded research and Alzheimer's detection work at UPenn Medicine.